BEP Supplementation Research in Bangladesh (JiVitA-BEP-IR)
Target-BEP
Balanced Energy and Protein (BEP) Supplementation Research in Bangladesh (JiVitA-BEP IR)
2 other identifiers
interventional
3,390
1 country
1
Brief Summary
The primary aim of the study is to evaluate the effect of fortified balanced energy and protein (BEP) supplementation vs. control (multiple micronutrient supplement, MMS) without targeting and with targeting (either by low prepregnancy BMI or low prepregnancy BMI and inadequate gestational weight gain) on birth weight and adverse birth outcomes of low birth weight (LBW \< 2500 g) and small-for-gestational age (SGA). To do this we are proposing a cluster-randomized, open labeled effectiveness trial with four arms The main question\[s\] it aims to answer are:
- 1.A daily BEP supplement from enrollment until birth
- 2.A daily BEP supplement from enrollment until birth, if they have low pre-pregnancy BMI with the rest receiving a MMS supplement
- 3.A daily BEP supplement from enrollment until birth, if they have low pre-pregnancy BMI with the rest receiving a MMS supplement or get switched to a BEP supplement based on inadequate gestational weight gain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 5, 2022
CompletedFirst Posted
Study publicly available on registry
October 12, 2022
CompletedStudy Start
First participant enrolled
October 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 23, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2026
ExpectedDecember 3, 2025
November 1, 2025
2.5 years
October 5, 2022
November 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Birth weight
Birth weight
Weight taken within 0-72 hours of birth
Low birth weight (weight < 2500 g) at birth
Dichotomous representation of the primary outcome
Weight taken within 0-72 hours of birth
Small-for-gestational age
Weight for a given gestational age lower than the 10th percentile of the reference standard
Measured within 0-72 hours of birth
Secondary Outcomes (6)
Birth length
Measured within 0-72 hours of birth
Gestational weight change
weight from pre-pregnancy to weight measured at birth
Proportion of inadequate gestational weight gain
From pre-pregnancy to birth
Head circumference at birth
at birth
Chest circumference at birth
at birth
- +1 more secondary outcomes
Other Outcomes (11)
Length-for-age Z score at birth
At Birth
weight-for-length Z score at birth
At Birth
Stunting at birth
At birth
- +8 more other outcomes
Study Arms (4)
Arm 1
ACTIVE COMPARATORMultiple Micronutrient Supplement for Pregnant women (UNIMMAP formulation) containing 15 nutrients all at a recommended daily allowance (RDA) for pregnancy to be consumed one-per-day during pregnancy
Arm 2
EXPERIMENTALBalanced energy and protein (BEP) food supplement (ready-to-use) for pregnant women containing 15 nutrients all at an RDA for pregnancy, and Ca and P. to be consumed one-per-day during pregnancy. BEP is recommended by the World Health Organization (WHO) for pregnancy use in undernourished contexts. Bangladesh is one such place. In this arm all pregnant women will receive this intervention
Arm 3
EXPERIMENTALBalanced energy and protein food supplement (ready-to-use) for pregnant women containing 15 nutrients all at an RDA for pregnancy, and Ca and P. to be consumed one-per-day during pregnancy. BEP is recommended by the WHO for pregnancy use in undernourished contexts. Bangladesh is one such place. In this arm, only low pre-pregnancy BMI women (\<18.5) will receive the BEP, the rest will receive the MMS.
Arm 4
EXPERIMENTALBalanced energy and protein food supplement (ready-to-use) for pregnant women containing 15 nutrients all at an RDA for pregnancy, and Ca and P. to be consumed one-per-day during pregnancy. BEP is recommended by the WHO for pregnancy use in undernourished contexts. Bangladesh is one such place. In this arm, only low pre-pregnancy BMI women (\<18.5) and those who have inadequate gestational weight gain during pregnancy will receive the BEP, the rest will receive the MMS.
Interventions
A fortified balanced energy and protein supplement providing both macro and micronutrients recommended for use during pregnancy in undernourished contexts.
Prenatal supplements containing vitamins and minerals - also called "multiple micronutrient" supplements will be used in the control group.
Eligibility Criteria
You may qualify if:
- Married women of reproductive age (15-35 y)
- living in the selected study area who are pregnant and consent to participate in the study.
You may not qualify if:
- Currently pregnant or lactating women (through 12 months postpartum),
- Married women who are sterilized or widowed/divorced will not be included in the pregnancy surveillance being used to identify newly pregnant women.
- Women with gestational age of \>=28 weeks of gestation using reported last menstrual period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
JiVitA Project
Rangpur City, Bangladesh
Related Publications (1)
Zavala E, Mohan D, Ali H, Siddiqua TJ, Haque R, Ayesha K, Ahsan KB, Sujan HM, Khaled N, Rahman A, Chakraborty B, Dyer B, Wu LSF, Kalbarczyk A, Erchick DJ, Thorne-Lyman AL, Tumilowicz A, Afsana K, Christian P. Targeting strategies for balanced energy and protein (BEP) supplementation in pregnancy: study protocol for the TARGET-BEP cluster-randomized controlled trial in rural Bangladesh. Trials. 2024 May 13;25(1):315. doi: 10.1186/s13063-024-08135-4.
PMID: 38741174DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Parul Christian, DrPH
Johns Hopkins University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 5, 2022
First Posted
October 12, 2022
Study Start
October 15, 2022
Primary Completion
April 23, 2025
Study Completion (Estimated)
May 31, 2026
Last Updated
December 3, 2025
Record last verified: 2025-11